KCa1.1 potassium channels regulate key proinflammatory and invasive properties of fibroblast-like synoviocytes in rheumatoid arthritis.

Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030, USA.
Journal of Biological Chemistry (Impact Factor: 4.6). 11/2011; 287(6):4014-22. DOI: 10.1074/jbc.M111.312264
Source: PubMed

ABSTRACT Fibroblast-like synoviocytes (FLS) play important roles in the pathogenesis of rheumatoid arthritis (RA). Potassium channels have regulatory roles in many cell functions. We have identified the calcium- and voltage-gated KCa1.1 channel (BK, Maxi-K, Slo1, KCNMA1) as the major potassium channel expressed at the plasma membrane of FLS isolated from patients with RA (RA-FLS). We further show that blocking this channel perturbs the calcium homeostasis of the cells and inhibits the proliferation, production of VEGF, IL-8, and pro-MMP-2, and migration and invasion of RA-FLS. Our findings indicate a regulatory role of KCa1.1 channels in RA-FLS function and suggest this channel as a potential target for the treatment of RA.


Available from: Liang Sun, Jul 19, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fibroblasts, which play an important role in cardiac function/dysfunction, including arrhythmogenesis, have voltage-dependent (Kv)-currents of unknown importance. Here, we assessed the differential expression of Kv-currents between atrial and ventricular fibroblasts from control dogs and dogs with an atrial arrhythmogenic substrate caused by congestive heart failure (CHF). Left-atrial (LA) and ventricular (LV) fibroblasts were freshly-isolated from control and CHF dogs (2-week ventricular tachypacing, 240 bpm). Kv-currents were measured with whole-cell voltage-clamp, mRNA by qPCR and fibroblast proliferation by (3)H-thymidine incorporation. Robust voltage-dependent TEA-sensitive K(+)-currents (IC50 ∼1 mM) were recorded. The morphologies and TEA-responses of LA and LV fibroblast Kv-currents were similar. LV-fibroblast Kv-current densities were significantly greater than LA, and Kv-current densities were significantly less in CHF than control. The mRNA expression of Kv-channel subunits Kv1.5 and Kv4.3 was less in LA vs LV fibroblasts and was down-regulated in CHF, consistent with K(+)-current recordings. Ca(2+)-dependent K(+)-channel subunit (KCa1.1) mRNA and currents were less expressed in LV vs LA fibroblasts. Inhibiting LA fibroblast K(+)-current with 1 mmol/L TEA or KCa1.1-current with paxilline increased proliferation. Fibroblast Kv-current expression is smaller in CHF vs control, as well as LA vs LV. KCa1.1-current is greater in LA vs LV. Suppressing Kv-current with TEA enhances fibroblast proliferation, suggesting that Kv-current might act to check fibroblast proliferation and that reduced Kv-current in CHF may contribute to fibrosis. Fibroblast Kv-current remodeling may play a role in the AF substrate; modulating fibroblast K(+)-channels may present a novel strategy to prevent fibrosis and AF.
    Cardiovascular Research 03/2014; 102(3). DOI:10.1093/cvr/cvu055 · 5.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Big Potassium (BK) ion channel is commonly known by a variety of names (Maxi-K, KCNMA1, slo, stretch-activated potassium channels, KCa1.1). Each name reflects a different physical property displayed by this single ion channel. This transmembrane channel is found on nearly every cell type of the body and has its own distinctive roles for that tissue type. The BKα channel contains the pore that releases potassium ions from intracellular stores. This ion channel is found on the cell membrane, endoplasmic reticulum, Golgi and mitochondria. Complex splicing pathways produce different isoforms. The BKα channels can be phosphorylated, palmitoylated and myristylated. BK is composed of a homo-tetramer that interacts with β and γ chains. These accessory proteins provide a further modulating effect on the functions of BKα channels. BK channels play important roles in cell division and migration. In this review, we will focus on the biology of the BK channel, especially its role, and its immune response towards cancer. Recent proteomic studies have linked BK channels with various proteins. Some of these interactions offer further insight into the role that BK channels have with cancers, especially with brain tumors. This review shows that BK channels have a complex interplay with intracellular components of cancer cells and still have plenty of secrets to be discovered.
    International Immunopharmacology 07/2014; 22(2). DOI:10.1016/j.intimp.2014.06.040 · 2.71 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Big Potassium (BK) ion channels have several splice variants. One splice variant initially described within human glioma cells is called the glioma BK channel (gBK). Using a gBK-specific antibody, we detected gBK within three human small cell lung cancer (SCLC) lines. Electrophysiology revealed that functional membrane channels were found on the SCLC cells. Prolonged exposure to BK channel activators caused the SCLC cells to swell within 20 minutes and resulted in their death within five hours. Transduction of BK-negative HEK cells with gBK produced functional gBK channels. Quantitative RT-PCR analysis using primers specific for gBK, but not with a lung-specific marker, Sox11, confirmed that advanced, late-stage human SCLC tissues strongly expressed gBK mRNA. Normal human lung tissue and early, lower stage SCLC resected tissues very weakly expressed this transcript. Immunofluorescence using the anti-gBK antibody confirmed that SCLC cells taken at the time of the autopsy intensely displayed this protein. gBK may represent a late-stage marker for SCLC. HLA-A*0201 restricted human CTL were generated in vitro using gBK peptide pulsed dendritic cells. The exposure of SCLC cells to interferon-γ (IFN-γ) increased the expression of HLA; these treated cells were killed by the CTL better than non-IFN-γ treated cells even though the IFN-γ treated SCLC cells displayed diminished gBK protein expression. Prolonged incubation with recombinant IFN-γ slowed the in vitro growth and prevented transmigration of the SCLC cells, suggesting IFN-γ might inhibit tumor growth in vivo. Immunotherapy targeting gBK might impede advancement to the terminal stage of SCLC via two pathways.
    American Journal of Translational Research 10/2014; 6(3):188-205. DOI:10.1158/1538-7445.AM2014-2895 · 3.23 Impact Factor